Total planned funding: $153,079,286
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Mozambique | $50,110,277 |
| South Africa | $16,424,193 |
| Zambia | $10,639,161 |
| Nigeria | $9,080,493 |
| Kenya | $8,359,896 |
| India | $7,814,357 |
| Indonesia | $4,976,794 |
| Burundi | $4,608,504 |
| Zimbabwe | $4,344,201 |
| Côte d'Ivoire | $4,155,736 |
| Asia Regional Program | $3,400,093 |
| Democratic Republic of the Congo | $3,390,975 |
| Malawi | $2,701,446 |
| Haiti | $2,616,452 |
| Caribbean Region | $2,525,420 |
| Papua New Guinea | $2,486,306 |
| Angola | $2,466,719 |
| Eswatini | $2,047,187 |
| Cambodia | $2,025,000 |
| Vietnam | $1,879,314 |
| Botswana | $1,840,003 |
| Uganda | $1,795,686 |
| Ethiopia | $1,324,111 |
| Tanzania | $1,250,000 |
| South Sudan | $566,962 |
| Dominican Republic | $250,000 |
| Central Asia Region | $0 |
Organizational Types
| NGO | $153,079,286 |
Program Areas
| Treatment | $47,528,537 |
| Care | $42,099,178 |
| Prevention | $34,023,569 |
| Testing | $16,986,131 |
| Governance and Systems | $12,441,871 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $43,208,444 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $25,765,491 |
| HKID: Care: Orphans and Vulnerable Children | $24,580,398 |
| HVCT: Testing: HIV Testing and Counseling | $16,986,131 |
| HBHC: Care: Adult Care and Support | $10,640,346 |
| OHSS: Health Systems Strengthening | $5,307,780 |
| HVSI: Strategic Information | $5,014,987 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $4,577,043 |
| PDCS: Care: Pediatric Care and Support | $4,480,222 |
| PDTX: Treatment: Pediatric Treatment | $4,320,093 |
| HVTB: Care: TB/HIV | $2,398,212 |
| HLAB: Laboratory Infrastructure | $2,119,104 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,093,360 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $842,969 |
| HMBL: Biomedical Prevention: Blood Safety | $334,929 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $232,093 |
| HMIN: Biomedical Prevention: Injection Safety | $177,684 |
| HTXD: Treatment: ARV Drugs | $0 |